Ketorolac hydrochloride is used as a 0.5% ophthalmic solution for the treatment of allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammatory pain; it is also a DDX3 inhibitor used in cancer research.